Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 5 Details of KRAS variants in Ugandan patients with colorectal cancer

From: The role of MLH1, MSH2 and MSH6 in the development of colorectal cancer in Uganda

No.

dbSNP.ID

HGVS.c

HGVS.p

Clinical significance

No. of cases with mutations

1

rs112445441

c.38G > A

p.Gly13Asp

Pathogenic

1

2

rs121913529

c.35G > A

p.Gly12Asp

Pathogenic

2

3

rs121913530

c.34G > A

p.Gly12Ser

Pathogenic

2

4

rs17851045

c.183 A > C

p.Gln61His

Pathogenic

1

5

-

c.129 A > G

p.Gln43Gln

Benign

1

6

rs202247812

c.347 A > G

p.Asn116Ser

Pathogenic

2

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us